https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-and-chinese-future-industry-investment-fund-establish-joint-venture-to-develop-new-medicines-in-china-27112017.html.Collaboration aims to accelerate local development of innovative medicines for patients in China and builds on AstraZeneca’s strong presence in the countryAstraZeneca today announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China to discover, develop and commercialise potential new medicines to help meet unmet needs globally, and to bring innovative new medicines to patients in China faster. FIIF is managed by the SDIC Fund Management Company (SDIC Fund), a private equity management company.The new company, Dizal Pharmaceutical, incorporates all scientific and technical capabilities of AstraZeneca
………………………………